LIN-39 is a neuron-specific developmental determinant of longevity in Caenorhabditis elegans with reduced insulin signaling
The nuclear chromatin landscape changes with age. Here, we investigate whether chromatin alterations distinguish also animals with unusual aging rates, focusing on Caenorhabditis elegans with reduced insulin/IGF-like signaling (IIS), i.e., daf-2 mutants. In these animals, enhancer regions that close with age tend to open and become transcriptionally active. We identify LIN-39 as a transcription factor (TF) binding these regions and being required for the longevity of daf-2 mutants. LIN-39 acts during late development in hermaphrodite-specific VC motor neurons - at a time when these undergo maturation. LIN-39-mediated longevity requires DAF-16/FOXO, suggesting cooperation of both TFs in VC neurons to open enhancers. Our findings argue that longevity of daf-2 mutant hermaphrodites relies on a signal emitted by properly matured VC neurons, and due to its essential role in this maturation process LIN-39 becomes a rare example of a development-specific lifespan determinant.
Authors
- Lluís Millán-Ariño (ORCID: https://orcid.org/0000-0001-8010-0463)
- Jérôme Salignon (ORCID: https://orcid.org/0000-0002-7242-3817)
- Alan Kavšek (ORCID: https://orcid.org/0009-0006-0310-6654)
- Peter Marcinkowski (ORCID: https://orcid.org/0009-0002-2172-4019)
- Christian G. Riedel (ORCID: https://orcid.org/0000-0002-3689-8022)
- Ilke Sen (ORCID: https://orcid.org/0000-0002-0033-4479)
Institutions
- Inserm (FR)
- Stockholm University (SE)
- Université Paris-Est Créteil (FR)
- Integrated Cardio Metabolic Centre (SE)
- Wenner-Gren Foundations (SE)
- Nutrition Sciences (Belgium) (BE)
- Institut Mondor de Recherche Biomédicale (FR)
Publication Details
- Journal
- Nature Communications
- Published
- 2025-07-16
- DOI
- https://doi.org/10.1038/s41467-025-61786-y
- Citations
- 1
- Primary Topic
- Genetics, Aging, and Longevity in Model Organisms
- Type
- article
- Field-Weighted Citation Impact
- 0.95
Funders
- Fred Hutchinson Cancer Research Center
- Johns Hopkins University
- Cancerfonden
- Karolinska Institutet
- Novo Nordisk
- Vetenskapsrådet
- Korea Advanced Institute of Science and Technology
- Novo Nordisk Fonden
- National Institutes of Health